Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Sch-55700 prevents a variety of eosinophilic responses in animal models

Oct. 7, 1999

PKC, cytokine inhibitors in development at AstraZeneca

Oct. 7, 1999

AstraZeneca receives FDA approval of Rhinocort Aqua Nasal Spray

Oct. 7, 1999

Nikken Chemicals prepares PDE4 inhibitors useful for allergic and inflammatory disorders

Oct. 6, 1999

Bayer's IL-4 antagonist for asthma enters clinical testing

Oct. 5, 1999

Zambon and Sheffield initiate MSI albuterol trial for treatment of pediatric asthma

Oct. 4, 1999

Gene Logic and UCB Research enter allergy and asthma gene expression agreement

Oct. 4, 1999

PDL and SB establish asthma therapy collaboration

Oct. 1, 1999

Banyu identifies potent, selective muscarinic M3 antagonist series

Sep. 30, 1999

Anilines from Yamanouchi exert selective inhibition of CRACC

Sep. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...